← Back to Clinical Trials
Recruiting NCT07208279

NCT07208279 Cognitive Vitality Pilot Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07208279
Status Recruiting
Phase
Sponsor Arizona State University
Condition Aging
Study Type INTERVENTIONAL
Enrollment 16 participants
Start Date 2025-09-01
Primary Completion 2026-08-11

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Axolt Brain SupplementBolero - Flavored Drink Placebo

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 16 participants in total. It began in 2025-09-01 with a primary completion date of 2026-08-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study's purpose is to evaluate the effects of a dietary supplement on cognitive function and psychological well-being in community-dwelling older adults aged 55+. The study involves taking a commercially available dietary supplement daily for 45 days. A 45-minute assessment will be conducted at the beginning and again at the end of the study.

Eligibility Criteria

Inclusion Criteria: * Adults aged 55 years and older * Live independently, * Self-report as healthy * Adequate vision * Fluent in English * No history of mild cognitive impairment * Currently not taking dietary supplements with the same active ingredients in Axolt or naturally flavored water * A Montreal Cognitive Assessment \[12\] (MOCA) score ≥ 24 * Able to provide written informed consent, and medical clearance to participate. Exclusion Criteria: * Previous participation in a cognitive dietary supplement study in the last 12 months * A score of \< 24 on the Montreal Cognitive Assessment (MoCA) as a potential risk for obtaining informed consent * History of seizures * Epilepsy * Parkinson's disease * History of severe head trauma * Uncontrolled hypertension * On psychoactive medications * Substance abuse * Unwilling or unable to discontinue current dietary supplements with similar ingredients * Planned surgery during the study period * Medications known to interact with active ingred

Frequently Asked Questions

Who can join the NCT07208279 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07208279 currently recruiting?

Yes, NCT07208279 is actively recruiting participants. Visit ClinicalTrials.gov or contact Arizona State University to inquire about joining.

Where is the NCT07208279 trial being conducted?

This trial is being conducted at West Palm Beach, United States.

Who is sponsoring the NCT07208279 clinical trial?

NCT07208279 is sponsored by Arizona State University. The trial plans to enroll 16 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology